TrialJournal of neuro-oncology2010

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.

Kurt A Jaeckle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.